JACC Specialty Journals

1673 Episodes

1. Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, and Outcomes | JACC: Advances

   Published: 4/23/2025
2. Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation | JACC: Advances

   Published: 4/23/2025
3. Comparative Congenital Cardiac Catheterization Registry Analysis From the United States and Low- and Middle-Income Countries | JACC: Advances

   Published: 4/23/2025
4. Chronic Inflammatory-Related Disease and Cardiovascular Disease in MESA | JACC: Advances

   Published: 4/23/2025
5. Cardiac Tamponade Complicating Type A Acute Aortic Dissection: Insights From 25 Years of Registry Research | JACC: Advances

   Published: 4/23/2025
6. Increased Endothelin-1 Is Associated With Morbidity in Single Ventricle Heart Disease in Children Undergoing Fontan Palliation | JACC: Advances

   Published: 4/23/2025
7. Impact of Artificial Intelligence-Enhanced Insertable Cardiac Monitors on Device Clinic Workflow and Resource Utilization | JACC: Advances

   Published: 4/23/2025
8. Gestational Blood Pressure Trajectories and 5-Year Postpartum Hypertension Risk in the MADRES Study | JACC: Advances

   Published: 4/23/2025
9. Association of Intramyocardial Hemorrhage With Inflammatory Biomarkers in Patients With ST-Segment Elevation Myocardial Infarction | JACC: Advances

   Published: 4/23/2025
10. Third-Trimester NT-proBNP for Pre-eclampsia Risk Prediction: A Comparison With sFlt-1/PlGF in a Population-Based Cohort | JACC: Advances

    Published: 4/23/2025
11. Aerobic Exercise Training, Biological Age, and Mortality in Chronic Heart Failure With Reduced Ejection Fraction | JACC: Advances

    Published: 4/23/2025
12. Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From AUGUSTUS | JACC: Advances

    Published: 4/23/2025
13. Polygenic Risk Scores in Myocardial Injury After Noncardiac Surgery: A VISION Substudy | JACC: Advances

    Published: 4/23/2025
14. Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance | JACC: CardioOncology

    Published: 4/15/2025
15. Cardiac Effects of Modern Breast Radiation Therapy in Patients Receiving Systemic Cancer Therapy | JACC: CardioOncology

    Published: 4/15/2025
16. Risk Factors of Left Ventricular Systolic Dysfunction in Immune Checkpoint Inhibitor-Myocarditis | JACC: CardioOncology

    Published: 4/15/2025
17. Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis | JACC: CardioOncology

    Published: 4/15/2025
18. Immune Checkpoint Inhibitor-Related Myocarditis with or without Concomitant Myopathy: Clinical Findings and Cardiovascular Outcomes | JACC: CardioOncology

    Published: 4/15/2025
19. A Multicenter Study of Contemporary Long-term Tafamidis Outcomes in Transthyretin Amyloid Cardiomyopathy | JACC: CardioOncology

    Published: 4/15/2025
20. April 2025 Issue Summary | JACC: CardioOncology

    Published: 4/15/2025